Clinical Assessment of GSK716155 for Type 2 Diabetes Mellitus

Clinical trial NCT00530309 · COMPLETED

Trial details

NCT number: NCT00530309
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2007-08-01
Primary completion: 2008-04-17
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.